New therapy targets Hippo pathway to fight treatment-resistant acute myeloid leukemia
Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effective in treatment-resistant acute myeloid leukemia (AML)…
Read the full articleYou might also wanna read
Epigenetic Therapy Shows Promise Against Treatment-Resistant AML
Researchers at The University of Texas MD Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effecti
Immune Cells Use Previously Unknown Pathway to Eliminate AML
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (A
Immune cells use previously unknown pathway to eliminate acute myeloid leukemia
Researchers at The University of Texas MD Anderson Cancer Center have discovered a new way in which T cells attack acute myeloid leukemia (A
UT MD Anderson Shares Latest Research Breakthroughs
* Cell therapies show encouraging results for a deadly brain infection, advanced kidney cancer * Tumor immune microenvironment studies revea
Epigenomic Analysis Reveals 16 New AML Subgroups and Drug Sensitivities
A chromatin-based study of 1,563 AML samples identifies novel epigenomic subgroups that enhance prognostic accuracy and uncover unexpected t
Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomes
Clonal hematopoiesis (CH) is the age-related expansion of mutated hematopoietic stem cells without hematologic abnormalities. In patients wi
Comments
Sign in to join the conversation.
No comments yet. Be the first.